QuantumCyte
Answers from every biopsy
- Headquarters
- Fremont, California
- Employees
- 11–50
- Founded
- 2013
- Business Model
- B2B
- Website
- quantumcyte.com
- Total Funding
- $2.1M
- Last Round
- $1.1M Series AAug 2023
About
QuantumCyte is a Fremont, California-based biotechnology company pioneering next-generation automated microdissection pathology through its Cytomask platform. The company combines patented science and technology to link digital pathology with molecular analysis, enabling high-precision tissue analysis from biopsy samples. QuantumCyte has collaborated with Roche on molecular pathology applications for precision medicine.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account